DIA
VRTX icon

Davidson Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Davidson Investment Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.2M Sell
48,710
-2,512
-5% -$1.11M 0.99% 31
2026
Q1 		$22.9M Sell
51,222
-13,005
-20% -$6.06M 0.99% 33
2025
Q4 		$29.1M Buy
64,227
+1,806
+3% +$778K 1.21% 20
2025
Q3 		$24.4M Sell
62,421
-1,268
-2% -$530K 1.04% 29
2025
Q2 		$28.4M Buy
63,689
+806
+1% +$371K 1.27% 25
2025
Q1 		$30.5M Buy
62,883
+1,722
+3% +$802K 1.51% 17
2024
Q4 		$24.6M Buy
61,161
+12,631
+26% +$5.85M 1.2% 26
2024
Q3 		$22.6M Buy
48,530
+2,191
+5% +$1.05M 1.09% 28
2024
Q2 		$21.7M Buy
46,339
+646
+1% +$280K 1.12% 27
2024
Q1 		$19.1M Buy
45,693
+1,174
+3% +$496K 0.99% 36
2023
Q4 		$18.1M Sell
44,519
-18,392
-29% -$6.79M 1.04% 39
2023
Q3 		$21.9M Buy
62,911
+1,318
+2% +$461K 1.39% 16
2023
Q2 		$21.7M Buy
61,593
+275
+0.4% +$92.7K 1.37% 15
2023
Q1 		$19.3M Buy
61,318
+6,415
+12% +$1.92M 1.27% 19
2022
Q4 		$15.9M Buy
54,903
+418
+0.8% +$127K 1.23% 32
2022
Q3 		$15.8M Sell
54,485
-11,337
-17% -$3.26M 1.32% 22
2022
Q2 		$18.5M Buy
65,822
+595
+0.9% +$159K 1.58% 17
2022
Q1 		$17M Buy
65,227
+918
+1% +$218K 1.23% 26
2021
Q4 		$14.1M Sell
64,309
-413
-0.6% -$80.3K 1.01% 45
2021
Q3 		$11.7M Buy
64,722
+2,548
+4% +$497K 0.92% 52
2021
Q2 		$12.5M Buy
+62,174
New +$13M 1% 47

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Davidson Investment Advisors's VRTX Position: Q2 2026 in Review

Davidson Investment Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 4.9% in Q2 2026, selling an estimated $1.11M and leaving 48,710 shares worth $24.2M. The position accounts for 0.99% of the portfolio, ranked #31.

Davidson Investment Advisors first reported a position in VRTX in Q2 2021 and has held it in 21 quarters since. The position peaked at $30.5M in Q1 2025. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Davidson Investment Advisors held 48,710 shares of Vertex Pharmaceuticals worth $24.2M as of Q2 2026.
  • Davidson Investment Advisors sold 2,512 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.11M.
  • Vertex Pharmaceuticals made up 0.99% of Davidson Investment Advisors's portfolio in Q2 2026, its #31 holding.
  • Davidson Investment Advisors first reported a position in Vertex Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
  • Davidson Investment Advisors's Vertex Pharmaceuticals position peaked at $30.5M in Q1 2025.
  • 334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Davidson Investment Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.